FDA-cleared profile

DS Core Detect

Dentsply Sirona, Inc.

DS Core Detect is a concurrent read, computer assisted detection software intended to aid the dentist in the incidental detection of permanent teeth that may be associated with periapical radiolucencies in CBCT images. The device is not intended as a replacement for a complete dentist's review or a replacement of their clinical judgment. The device is to be used by licensed dentists. The device is designed for patients who already have CBCT data obtained for other reasons. DS Core Detect does not generate X-ray images and does not provide an indication for taking such images. The device is intended for adults aged 22 years and older with permanent teeth.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
DS Core Detect is a concurrent read, computer assisted detection software intended to aid the dentist in the incidental detection of permanent teeth that may be associated with periapical radiolucencies in CBCT images. The device is not intended as a replacement for a complete dentist's review or a replacement of their clinical judgment. The device is to be used by licensed dentists. The device is designed for patients who already have CBCT data obtained for other reasons. DS Core Detect does not generate X-ray images and does not provide an indication for taking such images. The device is intended for adults aged 22 years and older with permanent teeth.
Public source Exact FDA submission Checked 2026-09-01

Exact-submission indication text from the ACR AI Central model card. FDA labeling remains controlling.

Intended users
Licensed dentists
Public source Exact FDA submission Checked 2026-09-01

Intended-user text reported in the exact-submission ACR model card.

Care setting and population
Adult
Public source Exact FDA submission Checked 2026-09-01

Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.

Workflow role
Detection, localization, or diagnostic support
Public source Exact FDA submission Checked 2026-09-01

Conservative normalization of explicit wording in an exact-submission source.

Required input
CT images or data. Inclusion criteria: Adult patients aged 22 years and older with permanent teeth who already have CBCT data obtained for other reasons; CBCT images of permanent teeth
Public source Exact FDA submission Checked 2026-09-01

Conservative normalization of explicit wording in an exact-submission source.

Output and human action
The device provides a list of teeth that may potentially have periapical radiolucency (PARL) and a corresponding PARL map to visualize where the PARL is detected. The user can confirm or reject each tooth flagged as potentially PARL positive. Two operating points are available: Standard sensitivity and High sensitivity.
Public source Exact FDA submission Checked 2026-09-01

Clinical output reported in the exact-submission ACR model card.

Limitations
Exclusion criteria: Patients under 22 years old, patients without permanent teeth
Public source Exact FDA submission Checked 2026-09-01

Limitations and supported-acquisition details reported in the exact-submission ACR model card.

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K253009
FDA source Exact FDA submission Checked 2026-08-31
Modality
CBCT
Public source Exact FDA submission Checked 2026-09-01

Imaging modality reported in the exact-submission ACR AI Central model card.

Anatomy
Dental/Maxillofacial
Public source Exact FDA submission Checked 2026-09-01

Anatomy normalized from explicit exact-submission ACR model-card wording.

Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2026-01-07
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
Research pending
Needs research Exact FDA submission Checked 2026-08-31

Attach protocol-level DICOM, HL7, FHIR, PACS, RIS, EHR, or orchestrator documentation.

Deployment and data flow
Research pending
Needs research Exact FDA submission Checked 2026-08-31

Attach an exact-product deployment and data-flow source.

Security and privacy
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

FDA authorization does not establish the current commercial security posture. Request data-flow diagrams, hosting and retention details, access controls, audit logging, attestations, and incident-response documentation.

Training and support
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.

Monitoring and change control
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
Study type: Both. Reported sensitivity: 78% (95% CI: 74%, 81%). Reported specificity: 93% (95% CI: 92%, 94%). Readers: 11. Reader-study sensitivity: 64.9% (95% CI: 53.5%, 76.3%). Reader-study specificity: 94.6% (95% CI: 91.5%, 97.6%)
Public source Exact FDA submission Checked 2026-09-01

Structured study metadata from the exact-submission ACR model card; this is not an independent evidence synthesis.

Reported sensitivity
78% (95% CI: 74%, 81%)
Public source Exact FDA submission Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
93% (95% CI: 92%, 94%)
Public source Exact FDA submission Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

DS Core Detect regulatory performance study summary

Stand-alone performance and reader study (ACR AI Central category) · Adult

exact submission · Tested version: Exact product version not reported; regulatory study summarized for FDA submission K253009 · Independence not established

K253009

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

FDA submission materials do not establish current commercial pricing. Request the pricing unit, term, minimum commitment, implementation fees, and included support from the vendor.

Reimbursement and coding
Research pending
Needs research Exact FDA submission Checked 2026-08-31

Determine whether any product-specific CPT/HCPCS pathway exists and separate it from billing for the underlying imaging service.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Automated sources checkedStatus
2026-09-04Last searched
17Fields reviewed
5Source classes checked
0Unreviewed PubMed leads
0Unreviewed trial leads
0Unreviewed FDA recall leads

Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, acr ai central product, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-02.

Alternatives

Related tools to compare

FDA-cleared K233925

Relu Creator

Relu BV

Relu Creator manages, transfers, displays, enhances, and analyzes dental and craniomaxillofacial image information and provides design input for dental solutions within the...

Modality
CBCT
Anatomy
Dental/Maxillofacial
Decision
2024-06-13
FDA-cleared K251514

Overjet CBCT Assist

Overjet, Inc.

Dental and craniomaxillofacial CBCT segmentation, measurement and visualization support

Modality
CBCT
Anatomy
Dental/Maxillofacial
Decision
2025-12-05
FDA-cleared K232698

NemoScan

Software Nemotec S.L.

NemoScan supports dental CT or cone-beam CT visualization, segmentation, implant and surgical planning, instrument positioning, and guide planning from preoperative maxillofacial...

Modality
CBCT
Anatomy
Dental/Maxillofacial
Decision
2024-01-18
FDA-cleared K231757

Ez3D-i /E3

Ewoosoft Co., Ltd

Ez3D-i/E3 provides dental and maxillofacial DICOM viewing, three-dimensional visualization, multiplanar reconstruction, two-dimensional analysis, implant simulation, canal...

Modality
CBCT
Anatomy
Dental/Maxillofacial
Decision
2023-07-14